Status:
NOT_YET_RECRUITING
Breathing Exercises of CardioBreath Application on Autonomic and Vascular Function in Hypertension
Lead Sponsor:
Instituto de Cardiologia do Rio Grande do Sul
Conditions:
Hypertension
Pre Hypertension
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Hypertension is one of the greatest public health challenges, affecting more than one billion people worldwide and representing a significant financial and public health burden. It is responsible for ...
Detailed Description
Systemic Arterial Hypertension (SAH) affects 1.33 billion people globally, representing 10% of global health costs. In the US, a study published in 2019 estimated that annual spending due to hypertens...
Eligibility Criteria
Inclusion
- BP\>130mmHg X 80mmHg or previous medical diagnosis of pre- hypertension or hypertension
Exclusion
- use of beta-blockers
- drugs that depress the central nervous system
- clinical conditions that prevent participation after evaluation by the team
- individuals without a cell phone or tablet (which would make the proposed study unfeasible
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2027
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06917729
Start Date
August 1 2025
End Date
September 20 2027
Last Update
April 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Cardiologia do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil, 90620-000
2
Instituto de Cardiologia do RioGrande do Sul
Porto Alegre, Rio Grande do Sul, Brazil, 90620-000